Events

Marie Skłodowska-Curie Actions Innovative Training Networks info session and workshop
JUN
Mon
24
07:00 - 16:00

This was 6 years ago

Location

University Foundation



Egmontstraat 11



1000 Brussel


Programmes
MSCA

NCP Flanders organised an info session on the 2020 call for Marie Skłodowska-Curie Actions Innovative Training Networks (ITN) and Research and Innovation Staff Exchange (RISE), in collaboration with the other Belgian National Contact Points at BELSPO and F.R.S.-FNRS.

The information session was organised to support researchers and host institutions with the preparation of their application for a Marie Skłodowska-Curie Actions Innovative Training Network and Research and Innovation Staff Exchange.

The presentations are available on the event website and below.

In the afternoon NCP Flanders and NCP FNRS co-organised a workshop on ITN proposal writing: more information

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.